Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Discover Exclusive Networks And 2 More Leading Growth Stocks On Euronext Paris

In This Article:

As the French CAC 40 Index experiences a modest rise amidst hopes of accelerated European Central Bank rate cuts, investors are keenly observing growth companies with substantial insider ownership on Euronext Paris. In this context, understanding what makes a good stock involves assessing not only its growth potential but also the confidence insiders have in their company's future, which can be particularly compelling during times of economic adjustment.

Top 10 Growth Companies With High Insider Ownership In France

Name

Insider Ownership

Earnings Growth

Groupe OKwind Société anonyme (ENXTPA:ALOKW)

20.6%

36%

VusionGroup (ENXTPA:VU)

13.4%

81.7%

Icape Holding (ENXTPA:ALICA)

30.2%

33.9%

Arcure (ENXTPA:ALCUR)

21.4%

26.6%

STIF Société anonyme (ENXTPA:ALSTI)

16.4%

22.9%

La Française de l'Energie (ENXTPA:FDE)

19.9%

31.9%

S.M.A.I.O (ENXTPA:ALSMA)

17.4%

35.2%

Adocia (ENXTPA:ADOC)

11.7%

64%

Munic (ENXTPA:ALMUN)

27.1%

174.1%

MedinCell (ENXTPA:MEDCL)

15.8%

93.9%

Click here to see the full list of 23 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Here's a peek at a few of the choices from the screener.

Exclusive Networks

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Exclusive Networks SA is a global cybersecurity specialist focused on digital infrastructure, with a market cap of €2.14 billion.

Operations: The company's revenue is segmented into €480 million from APAC, €4.19 billion from EMEA, and €705 million from the Americas.

Insider Ownership: 13.1%

Earnings Growth Forecast: 33.5% p.a.

Exclusive Networks is undergoing a significant transition as private equity firms Clayton, Dubilier & Rice and Permira aim to take it private, valuing the company at €2.2 billion. With 66.7% insider ownership by Permira and founder Olivier Breittmayer, this highlights strong insider control. Despite recent sales decline to €723 million for H1 2024, earnings are projected to grow significantly at 33.5% annually over the next three years, outpacing the French market growth of 12.1%.

ENXTPA:EXN Ownership Breakdown as at Oct 2024
ENXTPA:EXN Ownership Breakdown as at Oct 2024

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a pharmaceutical company in France that develops long-acting injectables across various therapeutic areas, with a market cap of €456.09 million.

Operations: The company's revenue segment consists solely of Pharmaceuticals, generating €11.95 million.

Insider Ownership: 15.8%

Earnings Growth Forecast: 93.9% p.a.


Waiting for permission
Allow microphone access to enable voice search

Try again.